Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Soligenix
Biotech
Soligenix shares take another dip as FDA requests 2nd trial
After the FDA denied approval for Soligenix’s rare cancer treatment in February, the agency has now said a second clinical trial will be needed.
Gabrielle Masson
Apr 14, 2023 11:02am
Soligenix stock sinks as FDA refuses lymphoma application
Feb 14, 2023 10:15am
Soligenix's stock climbs as phase 3 lymphoma trial hits goal
Mar 19, 2020 9:00am